Image not available

Al Edwan GM et al, 2017: Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis.

Al Edwan GM, Muheilan MM, Atta ON.
Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Jordan.

Abstract

OBJECTIVE: To evaluate the effect and safety of extracorporeal shockwave therapy (ESWT) on chronic pelvic pain syndrome (CPPS)/chronic abacterial prostatitis after failure of most other modalities of treatment, the maintenance of the treatment effect for up to one year post treatment and whether the patients are in need for further sessions.
MATERIALS AND METHODS: In a follow-up survey of 41 patients, the study inclusion criteria were CPPS patients who failed at least previously 3 modalities of treatment other than ESWT, who were treated by ESWT once a week for one month with a protocol of 2500 pulses at 1 bar over 13 min, Nonaddiction to drugs and narcotics. The exclusion criteria included being under treatment by another method another diagnosis such as prostate cancer, therapy plan alteration, and noninclination to continue this treatment. Then the patients were followed up at 2 weeks, 6 months and 12 months after finishing the course of ESWT. The study was designed as an open-label uncontrolled therapeutic clinical trial which was conducted in Jordan university hospital through the period 2015-2016. Data were compared using paired samples t-test.
RESULTS: Of our total 55 patients 8 of them did not complete the study protocol, 6 of them had missed follow up over the whole follow up period and 41 patients were evaluated. The patient's age group ranged between 18 and 78 years with a mean age of 42 and a median age of 43. The mean of National Institutes of Health -Chronic Prostatitis Symptom Index (NIH-CPSI), the International Prostate Symptom Score (IPSS), American Urological Association Quality of Life Due to Urinary Symptoms (AUA QOL_US) and International Index of Erectile Function (IIEF) were evaluated pre and post ESWT at 2 weeks, 6 months and 12 months and it showed statistically significant improvement in all parameters with maintenance of the effect without any significant side-effect of the treatment over the 12 months.
CONCLUSIONS: The evidence in this study would support the safety and efficacy of ESWT in refractory cases of CPPS at least for one year post treatment.

Ann Med Surg (Lond). 2017 Jan 6;14:12-17. doi: 10.1016/j.amsu.2016.12.051.

 

0
 

Comments 2

Guest - Bernhard H. Weber on Thursday, 20 July 2017 17:13

Dear Dr. Alken,

I appreciate your comments. Are you currently practicing the ESWT therapy in your fine offices in Germany?

Best greetings to Mannheim!

Dear Dr. Alken, I appreciate your comments. Are you currently practicing the ESWT therapy in your fine offices in Germany? Best greetings to Mannheim!
Peter Alken on Monday, 17 July 2017 07:40

Being a surgically very active urologist in Germany I rarely saw patients with abacterial prostatitis and I admit that diagnosis and therapy of this and similar disease entities were for me always close to psychiatric disorders. This publication and referenced publications suggest that regardless of my prejudice ESWT is a very useful treatment in these cases

Being a surgically very active urologist in Germany I rarely saw patients with abacterial prostatitis and I admit that diagnosis and therapy of this and similar disease entities were for me always close to psychiatric disorders. This publication and referenced publications suggest that regardless of my prejudice ESWT is a very useful treatment in these cases
Guest
Wednesday, 21 November 2018
STORZ MEDICAL AG
Lohstampfestrasse 8
8274 Tägerwilen
Switzerland
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05

www.storzmedical.com